RAC 2.20% $1.78 race oncology ltd

Ann: Professor Erin Howden Joins Race Oncology SAB, page-11

  1. 8,545 Posts.
    lightbulb Created with Sketch. 1403
    An excellent appointment.

    Q. What will Prof Howden do?
    A. Dr T, soon after the latest strategy was announced in November last year:
    "The Baker Institute and other research groups have a large amount of clinical data on the VO2Peak response to anthracyclines. This data can be used to construct what is a called a synthetic control arm similar to what we were going to do with the non-interventional trial that was cancelled."
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.